有奖答题🎁｜12月临床药理小测试～5
丁香园临床病例数据库
证书编号：
冻结核
您的案例《有奖答题🎁｜12月临床药理小测试～5》 经同行评议，被丁香园临床病例数据库收录。
收录时间 2025年5月22日
长按识别二维码
查看病例
查看病例
发布于 2024-12-17 · 浏览 482 · IP 上海上海
A patient suffering from refractory B-cell precursor acute lymphoblastic leukemia (ALL) requires treatment. After considering all treatment options, a decision is made to use a novel therapy that differs from CAR-T, but shares a common goal to bring cytotoxic T cells into close contact with their intended cancer cell targets. Which of the following has this mechanism of action?
A. atezolizumab (anti-PD-L1)
B. blinatumomab (BiTE)
C. rituximab
D. tocilizumab
----------------------------------------------
注意是单选题哦！前5名答对的站友有丁当奖励哦，大家积极参与吧～
最后编辑于 2024-12-17 · 浏览 482
